-
1
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease
-
Aaron SD, Vandemheen KL, Fergusson D, et al. 2007. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Ann Inter Med, 146:545-55.
-
(2007)
Ann Inter Med
, vol.146
, pp. 545-555
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
-
2
-
-
60249084256
-
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
-
American Thoracic Society
-
American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 165:838-44.
-
(1995)
Am J Respir Crit Care Med
, vol.165
, pp. 838-844
-
-
-
3
-
-
60249099238
-
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilar on the rate of decline of FEV1. The Lung Health Study
-
Anthonisen NR, Connett JE, Kiley JP, et al. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilar on the rate of decline of FEV1. The Lung Health Study. JAMA, 23:241-49.
-
(1994)
JAMA
, vol.23
, pp. 241-249
-
-
Anthonisen, N.R.1
Connett, J.E.2
Kiley, J.P.3
-
4
-
-
13444250953
-
The effect of a smoking cessation intervention on 14.5-year mortality
-
Anthonisen NR, Skeans MA, Wise RA, et al. 2005. The effect of a smoking cessation intervention on 14.5-year mortality. Ann Inter Med, 142:233-39.
-
(2005)
Ann Inter Med
, vol.142
, pp. 233-239
-
-
Anthonisen, N.R.1
Skeans, M.A.2
Wise, R.A.3
-
5
-
-
2942735127
-
Small Airways in COPD
-
Barnes PJ. 2004. Small Airways in COPD. N Engl J Med, 350:2635-37.
-
(2004)
N Engl J Med
, vol.350
, pp. 2635-2637
-
-
Barnes, P.J.1
-
6
-
-
1542405163
-
National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care
-
British Thoracic Society
-
British Thoracic Society. 2004. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax, 59 (Suppl 1):1-232.
-
(2004)
Thorax
, vol.59
, Issue.SUPPL. 1
, pp. 1-232
-
-
-
7
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive Pulmonary disease
-
Calverley PMA, Anderson JA, Celli BR, et al. 2007. Salmeterol and fluticasone propionate and survival in chronic obstructive Pulmonary disease. N Engl J Med, 356:775-89.
-
(2007)
N Engl J Med
, vol.356
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.R.3
-
8
-
-
0347473812
-
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
-
Calverley PM, Boonsawat W, Cseke Z, et al. 2003a. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J, 22:912-19.
-
(2003)
Eur Respir J
, vol.22
, pp. 912-919
-
-
Calverley, P.M.1
Boonsawat, W.2
Cseke, Z.3
-
9
-
-
13444269557
-
Flow limitation and dynamic hyperinflation: Key concepts in modern respiratory physiology
-
Calverley PMA, Koulouris NG. 2005. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J, 25:186-99.
-
(2005)
Eur Respir J
, vol.25
, pp. 186-199
-
-
Calverley, P.M.A.1
Koulouris, N.G.2
-
10
-
-
0037425745
-
-
2-agonists) study group, et al. 2003b. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet, 361:449-56.
-
2-agonists) study group, et al. 2003b. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet, 361:449-56.
-
-
-
-
11
-
-
34447498332
-
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
-
Cazzola M, Andò F, Santus P, et al. 2007a. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD. Pulm Pharmacol Ther, 20:556-61.
-
(2007)
Pulm Pharmacol Ther
, vol.20
, pp. 556-561
-
-
Cazzola, M.1
Andò, F.2
Santus, P.3
-
12
-
-
1942531936
-
2-agonists and corticosteroids in stable COPD
-
2-agonists and corticosteroids in stable COPD. Chest, 126:220-37.
-
(2004)
Chest
, vol.126
, pp. 220-237
-
-
Cazzola, M.1
Dahl, R.2
-
13
-
-
0345414503
-
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD
-
Cazzola M, Di Marco F, Santus P, et al. 2004. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther, 17:35-39.
-
(2004)
Pulm Pharmacol Ther
, vol.17
, pp. 35-39
-
-
Cazzola, M.1
Di Marco, F.2
Santus, P.3
-
15
-
-
0031810916
-
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia
-
Cazzola M, Imperatore F, Salzillo A, et al. 1998. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia. Chest, 114:411-15.
-
(1998)
Chest
, vol.114
, pp. 411-415
-
-
Cazzola, M.1
Imperatore, F.2
Salzillo, A.3
-
17
-
-
33751193695
-
The effective treatment of COPD: Anticholinergics and what else?
-
Cazzola M, Matera MG. 2006. The effective treatment of COPD: Anticholinergics and what else? Drug Discov Today: Ther Strat, 3:277-86.
-
(2006)
Drug Discov Today: Ther Strat
, vol.3
, pp. 277-286
-
-
Cazzola, M.1
Matera, M.G.2
-
18
-
-
33947723601
-
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: A pilot study
-
Cazzola M, Matera MG. 2007. The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: A pilot study. Respir Med, 101:957-62.
-
(2007)
Respir Med
, vol.101
, pp. 957-962
-
-
Cazzola, M.1
Matera, M.G.2
-
19
-
-
23744435643
-
2-adrenoceptor agonists. cardiovascular safety in patients with obstructive lung disease
-
2-adrenoceptor agonists. cardiovascular safety in patients with obstructive lung disease. Drugs, 65:1595-610.
-
(2005)
Drugs
, vol.65
, pp. 1595-1610
-
-
Cazzola, M.1
Matera, M.G.2
Donner, C.F.3
-
20
-
-
30544443706
-
Effect of formoterol/ budesonide combination on arterial blood gases in patients with acute exacerbation of COPD
-
Cazzola M, Noschese P, De Michele F, et al. 2006. Effect of formoterol/ budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. Respir Med, 100:212-17.
-
(2006)
Respir Med
, vol.100
, pp. 212-217
-
-
Cazzola, M.1
Noschese, P.2
De Michele, F.3
-
21
-
-
1442306237
-
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
-
Celli BR, Cole CG, Marin JM, et al. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350:1005-12.
-
(2004)
N Engl J Med
, vol.350
, pp. 1005-1012
-
-
Celli, B.R.1
Cole, C.G.2
Marin, J.M.3
-
22
-
-
1842552109
-
-
Celli BR, MacNee W, ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 23:932-46.
-
Celli BR, MacNee W, ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 23:932-46.
-
-
-
-
23
-
-
28244446602
-
Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease
-
Centanni S, Di Marco F. 2005. Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother, 6:2525-34.
-
(2005)
Expert Opin Pharmacother
, vol.6
, pp. 2525-2534
-
-
Centanni, S.1
Di Marco, F.2
-
24
-
-
33748902214
-
The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function
-
Cooper CB. 2006. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med, 119:S21-S31.
-
(2006)
Am J Med
, vol.119
-
-
Cooper, C.B.1
-
25
-
-
15044362349
-
Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease
-
Cooper CB, Tashkin DP. 2005. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. BMJ, 330:640-44.
-
(2005)
BMJ
, vol.330
, pp. 640-644
-
-
Cooper, C.B.1
Tashkin, D.P.2
-
26
-
-
0017816443
-
The relations between structural changes in small airways and pulmonary function tests
-
Cosio M, Ghezzo H, Hogg JC, et al. 1978. The relations between structural changes in small airways and pulmonary function tests. N Engl J Med, 298:1277-81.
-
(1978)
N Engl J Med
, vol.298
, pp. 1277-1281
-
-
Cosio, M.1
Ghezzo, H.2
Hogg, J.C.3
-
27
-
-
0345074173
-
Effect of inhaled bronchodilators on inspiratory capacity and dysnoea at rest in COPD
-
Di Marco F, Milic-Emili J, Boveri B, et al. 2003. Effect of inhaled bronchodilators on inspiratory capacity and dysnoea at rest in COPD. Eur Respir J, 21:86-94.
-
(2003)
Eur Respir J
, vol.21
, pp. 86-94
-
-
Di Marco, F.1
Milic-Emili, J.2
Boveri, B.3
-
28
-
-
0033883907
-
Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest
-
Diaz O, Villafranca C, Ghezzo H, et al. 2000. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J, 16:269-75.
-
(2000)
Eur Respir J
, vol.16
, pp. 269-275
-
-
Diaz, O.1
Villafranca, C.2
Ghezzo, H.3
-
29
-
-
60249090309
-
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
-
Gayan-Ramirez G, Koulouris N, Roca J, et al. 2006. Respiratory and skeletal muscles in chronic obstructive pulmonary disease. Eur Respir Mon, 38:201-23.
-
(2006)
Eur Respir Mon
, vol.38
, pp. 201-223
-
-
Gayan-Ramirez, G.1
Koulouris, N.2
Roca, J.3
-
30
-
-
0037092554
-
β-agonist intrinsic efficacy: Measurement and clinical significance
-
Hanania NA, Sharafkhaneh A, Barber R, et al. 2002. β-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med, 165:1353-8.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 1353-1358
-
-
Hanania, N.A.1
Sharafkhaneh, A.2
Barber, R.3
-
31
-
-
4344675455
-
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
-
Hogg JC. 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet, 364:709-21.
-
(2004)
Lancet
, vol.364
, pp. 709-721
-
-
Hogg, J.C.1
-
32
-
-
2942720573
-
The nature of small airway obstruction in chronic obstructive pulmonary disease
-
Hogg JC, Chu F, Utokaparch S, et al. 2004. The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med, 350:2645-53.
-
(2004)
N Engl J Med
, vol.350
, pp. 2645-2653
-
-
Hogg, J.C.1
Chu, F.2
Utokaparch, S.3
-
33
-
-
0014424329
-
Site and nature of airways obstruction in chronic obstructive lung disease
-
Hogg JC, Macklem PT, Thurlbeck WM. 1968. Site and nature of airways obstruction in chronic obstructive lung disease. N Engl J Med, 278:1355-60.
-
(1968)
N Engl J Med
, vol.278
, pp. 1355-1360
-
-
Hogg, J.C.1
Macklem, P.T.2
Thurlbeck, W.M.3
-
34
-
-
0036303552
-
Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD. Results of a randomized, double-blind clinical study
-
Kottakis J, Della Cioppa G, Creemers J, et al. 2002. Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD. Results of a randomized, double-blind clinical study. Can Respir J, 9:107-15.
-
(2002)
Can Respir J
, vol.9
, pp. 107-115
-
-
Kottakis, J.1
Della Cioppa, G.2
Creemers, J.3
-
38
-
-
0242577942
-
Contemporary management of chronic obstructive pulmonary disease
-
Man SFP, McAlister FA, Anthonisen NR, et al. 2003. Contemporary management of chronic obstructive pulmonary disease. JAMA, 290:2313-16.
-
(2003)
JAMA
, vol.290
, pp. 2313-2316
-
-
Man, S.F.P.1
McAlister, F.A.2
Anthonisen, N.R.3
-
39
-
-
2942692139
-
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
-
Man WDC, Mustfa N, Nikoletou D, et al. 2004. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax, 59:471-76.
-
(2004)
Thorax
, vol.59
, pp. 471-476
-
-
Man, W.D.C.1
Mustfa, N.2
Nikoletou, D.3
-
40
-
-
26444543237
-
An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses
-
Matera MG, Sanduzzi A, Ponticiello A, et al. 2005. An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses. Respiration, 72:466-70.
-
(2005)
Respiration
, vol.72
, pp. 466-470
-
-
Matera, M.G.1
Sanduzzi, A.2
Ponticiello, A.3
-
41
-
-
0034705111
-
Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression
-
Murray DR, Prabhu SD, Chandrasekar B. 2000. Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation, 101:2338-41.
-
(2000)
Circulation
, vol.101
, pp. 2338-2341
-
-
Murray, D.R.1
Prabhu, S.D.2
Chandrasekar, B.3
-
42
-
-
0035985520
-
Chronically inhaled salmeterol improves pulmonary function in heart failure
-
Ng TM, Munger MA, Lombatri WL, et al. 2002. Chronically inhaled salmeterol improves pulmonary function in heart failure. J Cardiovasc Pharmacol, 40:140-45.
-
(2002)
J Cardiovasc Pharmacol
, vol.40
, pp. 140-145
-
-
Ng, T.M.1
Munger, M.A.2
Lombatri, W.L.3
-
43
-
-
0035446990
-
Dynamic hyperinflaction and exercise intolerance in chronic obstructive pulmonary disease
-
O'Donnell DE, Lam M, Webb KA. 2001. Dynamic hyperinflaction and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164:770-77.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 770-777
-
-
O'Donnell, D.E.1
Lam, M.2
Webb, K.A.3
-
44
-
-
3543055330
-
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
-
O'Donnell DE, Voduc N, Fitzpatrick M, et al. 2004. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J, 24:86-94.
-
(2004)
Eur Respir J
, vol.24
, pp. 86-94
-
-
O'Donnell, D.E.1
Voduc, N.2
Fitzpatrick, M.3
-
45
-
-
0035035768
-
Global strategy for the diagnosis, management and prevention of chronich obstructive pulmonary disease
-
Pauwels RA, Buist AS, Calverley PMA, et al. 2001. Global strategy for the diagnosis, management and prevention of chronich obstructive pulmonary disease. Am J Respir Crit Care Med, 163:1256-76.
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 1256-1276
-
-
Pauwels, R.A.1
Buist, A.S.2
Calverley, P.M.A.3
-
47
-
-
38449115415
-
Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline from the American College of Physicians
-
Qaseem A, Snow V, Shekelle P, et al. 2007. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Inter Med, 147:633-38.
-
(2007)
Ann Inter Med
, vol.147
, pp. 633-638
-
-
Qaseem, A.1
Snow, V.2
Shekelle, P.3
-
48
-
-
33847161293
-
Treating COPD - The TORCH Trial, P values, and the Dodo
-
Rabe KF. 2007. Treating COPD - The TORCH Trial, P values, and the Dodo. N Engl J Med, 356:851-54.
-
(2007)
N Engl J Med
, vol.356
, pp. 851-854
-
-
Rabe, K.F.1
-
49
-
-
34548660457
-
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary
-
Rabe KF, Hurd SS, Anzueto A, et al. 2007. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 176:532-55.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 532-555
-
-
Rabe, K.F.1
Hurd, S.S.2
Anzueto, A.3
-
50
-
-
0038467559
-
Cardiovascular safety of salmeterol in patients with COPD
-
Reisner C, Funck-Brentano C, Fischer T, et al. 2003. Cardiovascular safety of salmeterol in patients with COPD. Chest, 123:1817-24.
-
(2003)
Chest
, vol.123
, pp. 1817-1824
-
-
Reisner, C.1
Funck-Brentano, C.2
Fischer, T.3
-
51
-
-
73549083024
-
Bronchodilators in chronic obstructive pulmonary disease
-
Rennard SI, Calverley PMA. 2006. Bronchodilators in chronic obstructive pulmonary disease. Eur Respir Mon, 38:266-80.
-
(2006)
Eur Respir Mon
, vol.38
, pp. 266-280
-
-
Rennard, S.I.1
Calverley, P.M.A.2
-
52
-
-
10644240946
-
Mucociliary dysfunction in COPD: Effect of current pharmacotherapeutic options
-
Rogers DF. 2005. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther, 18:1-8.
-
(2005)
Pulm Pharmacol Ther
, vol.18
, pp. 1-8
-
-
Rogers, D.F.1
-
53
-
-
0036206172
-
Comparison of the efficacy, tolerability and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD
-
Rossi A, Kristufek P, Levine BE, et al. 2002. Comparison of the efficacy, tolerability and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest, 121:1058-69.
-
(2002)
Chest
, vol.121
, pp. 1058-1069
-
-
Rossi, A.1
Kristufek, P.2
Levine, B.E.3
-
54
-
-
0000313603
-
Dynamic Hyperinflation
-
Marini JJ and Roussos C eds, Berlin: Springer-Verlag. p
-
Rossi A, Polese G, Brandi G. 1991. Dynamic Hyperinflation. In: Marini JJ and Roussos C (eds). Ventilatory Failure. Berlin: Springer-Verlag. p 199-218.
-
(1991)
Ventilatory Failure
, pp. 199-218
-
-
Rossi, A.1
Polese, G.2
Brandi, G.3
-
55
-
-
0033374914
-
Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD
-
Sakamaki F, Satoh T, Nagaya N, et al. 1999. Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD. Chest, 116:1575-81.
-
(1999)
Chest
, vol.116
, pp. 1575-1581
-
-
Sakamaki, F.1
Satoh, T.2
Nagaya, N.3
-
56
-
-
33745306721
-
Meta-analysis: Effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths
-
Salpeter SR, Buckley NS, Ormiston TM, et al. 2006a. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Inter Med, 144:904-12.
-
(2006)
Ann Inter Med
, vol.144
, pp. 904-912
-
-
Salpeter, S.R.1
Buckley, N.S.2
Ormiston, T.M.3
-
57
-
-
33748369326
-
Meta-Analysis: Anticholinergic, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD
-
Salpeter SR, Buckley NS, Salpeter EE. 2006b. Meta-Analysis: Anticholinergic, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med, 21:1011-19.
-
(2006)
J Gen Intern Med
, vol.21
, pp. 1011-1019
-
-
Salpeter, S.R.1
Buckley, N.S.2
Salpeter, E.E.3
-
58
-
-
2942744546
-
Cardiovascular effects of β-agonists in patients with asthma and COPD
-
Salpeter SR, Ormiston TM, Salpeter EE. 2004. Cardiovascular effects of β-agonists in patients with asthma and COPD. Chest, 125:2309-21.
-
(2004)
Chest
, vol.125
, pp. 2309-2321
-
-
Salpeter, S.R.1
Ormiston, T.M.2
Salpeter, E.E.3
-
60
-
-
0029156848
-
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
-
Siafakas NM, Vermeire P, Pride NB, et al. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J, 8:1398-420.
-
(1995)
Eur Respir J
, vol.8
, pp. 1398-1420
-
-
Siafakas, N.M.1
Vermeire, P.2
Pride, N.B.3
-
61
-
-
0242577949
-
Contemporary management of chronic obstructive pulmonary disease
-
Sin DD, McAlister FA, Man SFP, et al. 2003. Contemporary management of chronic obstructive pulmonary disease. JAMA, 290:2301-12.
-
(2003)
JAMA
, vol.290
, pp. 2301-2312
-
-
Sin, D.D.1
McAlister, F.A.2
Man, S.F.P.3
-
62
-
-
0028913892
-
The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD
-
Stewart AG, Waterhouse JC, Howard P. 1995. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med, 89:79-84.
-
(1995)
Respir Med
, vol.89
, pp. 79-84
-
-
Stewart, A.G.1
Waterhouse, J.C.2
Howard, P.3
-
63
-
-
2942729608
-
Management of chronic obstructive pulmonary disease
-
Sutherland ER, Cherniack RM. 2004. Management of chronic obstructive pulmonary disease. N Engl J Med, 350:2689-97.
-
(2004)
N Engl J Med
, vol.350
, pp. 2689-2697
-
-
Sutherland, E.R.1
Cherniack, R.M.2
-
64
-
-
0037246566
-
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
-
Szafranski W, Cukier A, Ramirez R, et al. 2003. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J, 21:74-81.
-
(2003)
Eur Respir J
, vol.21
, pp. 74-81
-
-
Szafranski, W.1
Cukier, A.2
Ramirez, R.3
-
65
-
-
1642493871
-
The role of long-acting bronchodilators in the management of stable COPD
-
Tashkin DP, Cooper GB. 2004. The role of long-acting bronchodilators in the management of stable COPD. Chest, 125:249-59.
-
(2004)
Chest
, vol.125
, pp. 249-259
-
-
Tashkin, D.P.1
Cooper, G.B.2
-
66
-
-
0037502770
-
2-adrenoceptor agonists or tiotropium bromide for patients with COPD: Is combination therapy justified?
-
2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? Curr Opin Pharmacol, 3:270-6.
-
(2003)
Curr Opin Pharmacol
, vol.3
, pp. 270-276
-
-
Tennant, R.C.1
Erin, E.M.2
Barnes, P.J.3
-
67
-
-
4344710679
-
The TORCH (Towards a Revolution in COPD Health) survival study protocol
-
The TORCH Study Group
-
The TORCH Study Group. 2004. The TORCH (Towards a Revolution in COPD Health) survival study protocol. Eur Respir J, 24:206-10.
-
(2004)
Eur Respir J
, vol.24
, pp. 206-210
-
-
-
68
-
-
23144457098
-
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
-
Van Noord JA, Aumann JL, Janssens E, et al. 2005. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J, 26:214-22.
-
(2005)
Eur Respir J
, vol.26
, pp. 214-222
-
-
Van Noord, J.A.1
Aumann, J.L.2
Janssens, E.3
-
69
-
-
33645116728
-
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
-
Van Noord JA, Aumann JL, Janssens E, et al. 2006. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest, 129:509-17.
-
(2006)
Chest
, vol.129
, pp. 509-517
-
-
Van Noord, J.A.1
Aumann, J.L.2
Janssens, E.3
-
70
-
-
0018092991
-
19 78. Ventilation-perfusion inequality in asymptomatic asthma
-
Wagner PD, Dantzker DR, Lacovoni VE, et al. 19 78. Ventilation-perfusion inequality in asymptomatic asthma. Am Rev Respir Dis, 118:511-24.
-
Am Rev Respir Dis
, vol.118
, pp. 511-524
-
-
Wagner, P.D.1
Dantzker, D.R.2
Lacovoni, V.E.3
-
71
-
-
0033995550
-
β-Agonistic bronchodilators: Comparison of dose/response in working rat hearts
-
Zimmer G, Dahinten A, Fitzner A, et al. 2000. β-Agonistic bronchodilators: comparison of dose/response in working rat hearts. Chest, 117:519-29.
-
(2000)
Chest
, vol.117
, pp. 519-529
-
-
Zimmer, G.1
Dahinten, A.2
Fitzner, A.3
|